Pharmacogenomics, or or how to cut the prices of pharmaceutical R&D

被引：0
|
作者：
Amir-Aslani, A
机构：
来源：
BIOFUTUR | 2006年 / 262期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：45 / 47
页数：3
相关论文
共 50 条
  • [21] Systems biology in pharmaceutical R&D
    Oresic, Matej
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 34 (01) : S23 - S23
  • [22] The productivity crisis in pharmaceutical R&D
    Fabio Pammolli
    Laura Magazzini
    Massimo Riccaboni
    Nature Reviews Drug Discovery, 2011, 10 : 428 - 438
  • [23] How to improve R&D productivity: the pharmaceutical industry's grand challenge
    Steven M. Paul
    Daniel S. Mytelka
    Christopher T. Dunwiddie
    Charles C. Persinger
    Bernard H. Munos
    Stacy R. Lindborg
    Aaron L. Schacht
    Nature Reviews Drug Discovery, 2010, 9 : 203 - 214
  • [24] How to improve R&D productivity: the pharmaceutical industry's grand challenge
    Paul, Steven M.
    Mytelka, Daniel S.
    Dunwiddie, Christopher T.
    Persinger, Charles C.
    Munos, Bernard H.
    Lindborg, Stacy R.
    Schacht, Aaron L.
    NATURE REVIEWS DRUG DISCOVERY, 2010, 9 (03) : 203 - 214
  • [25] International R&D spillovers and asset prices
    Gavazzoni, Federico
    Santacreu, Ana Maria
    JOURNAL OF FINANCIAL ECONOMICS, 2020, 136 (02) : 330 - 354
  • [26] Capitalization of R&D and the informativeness of stock prices
    Oswald, Dennis R.
    Zarowin, Paul
    EUROPEAN ACCOUNTING REVIEW, 2007, 16 (04) : 703 - 726
  • [27] R&D, TECHNOLOGY SPILLOVERS AND STOCK PRICES
    Madsen, Jakob B.
    Barner, Martin
    Faro, Christian
    PACIFIC ECONOMIC REVIEW, 2008, 13 (05) : 620 - 631
  • [28] Physical sciences R&D 'must not be cut'
    不详
    PROFESSIONAL ENGINEERING, 2009, 22 (05) : 11 - 11
  • [29] Small firms cut R&D spending
    Brainard, Jeffrey
    SCIENCE, 2019, 364 (6438) : 310 - 311
  • [30] SYNGENTA TO CUT R&D, OTHER JOBS
    不详
    CHEMICAL & ENGINEERING NEWS, 2014, 92 (48) : 17 - 17
12345